- Trials with a EudraCT protocol (496)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
496 result(s) found for: High cholesterol.
Displaying page 1 of 25.
EudraCT Number: 2005-002851-41 | Sponsor Protocol Number: 1228.1 | Start Date*: 2006-03-07 |
Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG | ||
Full Title: Reduced factorial design, randomized, double blind trial comparing combinations of telmisartan 20 or 80 mg and simvastatin 20 or 40 mg with single component therapies in the treatment of hypertensi... | ||
Medical condition: hypertension and dyslipidaemia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) SE (Completed) SK (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-000486-37 | Sponsor Protocol Number: 2013-000486-37 | Start Date*: 2013-07-16 | |||||||||||
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | |||||||||||||
Full Title: Rosuvastatin versus Protease Inhibitor Switching for Hypercholesterolaemia in HIV-infected Adults. | |||||||||||||
Medical condition: HIV AND HYPERCHOLESTEROLAEMIA | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-006550-31 | Sponsor Protocol Number: SEC-ES-BempeDACS-2021 | Start Date*: 2022-04-05 |
Sponsor Name:SPANISH SOCIETY OF CARDIOLOGY | ||
Full Title: Efficacy and Security of BempeDoic acid in Acute Coronary Syndrome | ||
Medical condition: Acute coronary syndrome with poor LDL-cholesterol control | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-008376-14 | Sponsor Protocol Number: COD_REG_46_DGR _13751_07 | Start Date*: 2009-02-24 | |||||||||||
Sponsor Name:AZIENDA ASL BRESCIA | |||||||||||||
Full Title: A PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED TRIAL TO INVESTIGATE EFFICACY AND SAFETY OF COMBINED TREATMENT OF GUGGULU AND TRIPHALA FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA AND OVERWEIGHT IN SUB... | |||||||||||||
Medical condition: high blood cholesterol overweight | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-005064-22 | Sponsor Protocol Number: TA-8995-301 | Start Date*: 2022-09-22 | ||||||||||||||||
Sponsor Name:NewAmsterdam Pharma B.V. | ||||||||||||||||||
Full Title: Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies (BROOKLYN): A Placebo-Controlled, Double-Blind, Randomized, Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Partici... | ||||||||||||||||||
Medical condition: dyslipidemia heterozygous familial hypercholesterolemia (HeFH) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) NL (Completed) CZ (Completed) PL (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005643-24 | Sponsor Protocol Number: TA-8995-03 | Start Date*: 2013-07-29 | |||||||||||
Sponsor Name:Xention Limited | |||||||||||||
Full Title: A Multi-Centre, Randomised, Double Blind, Placebo Controlled, Parallel Group Study of TA 8995 in Patients with Mild Dyslipidaemia, Alone and In Combination with Statin Therapy | |||||||||||||
Medical condition: Mild dyslipidaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001638-33 | Sponsor Protocol Number: IKEM-CEM-01 | Start Date*: 2012-10-10 | |||||||||||
Sponsor Name:Institute for Clinical and Experimental Medicine | |||||||||||||
Full Title: Cholesterol 7alpha-hydroxylase polymorphism as a predictor cholesterolemia responsiveness | |||||||||||||
Medical condition: hypercholesterolemia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002630-32 | Sponsor Protocol Number: NN6435-4697 | Start Date*: 2021-07-27 | ||||||||||||||||
Sponsor Name:Novo Nordisk A/S | ||||||||||||||||||
Full Title: Dose response and safety of an oral PCSK9i, NNC0385-0434, in patients with established atherosclerotic cardiovascular disease (ASCVD) or ASCVD risk on maximally tolerated statin dose and other lipi... | ||||||||||||||||||
Medical condition: Established atherosclerotic cardiovascular disease (ASCVD) or ASCVD risk Elevated cholesterol | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) GR (Completed) NL (Completed) BE (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-003191-35 | Sponsor Protocol Number: KBT-003 | Start Date*: 2006-10-09 | |||||||||||
Sponsor Name:Karo Bio AB | |||||||||||||
Full Title: A placebo controlled, double blind, randomised, 12-week, phase II study to assess the safety and efficacy of KB2115 in patients with primary hypercholesterolemia | |||||||||||||
Medical condition: Primary Hypercholesterolemia. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005002-40 | Sponsor Protocol Number: 0653A-134 | Start Date*: 2008-11-18 | |||||||||||
Sponsor Name:Merck & Co., Inc. | |||||||||||||
Full Title: "Estudio aleatorizado, doble ciego, con control activo, multicéntrico en pacientes con hipercolesterolemia primaria y alto riesgo cardiovascular y no controlados adecuadamente con Atorvastatina 20 ... | |||||||||||||
Medical condition: hipercolesterolemia primaria primary hypercholesterolemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) HU (Completed) PT (Completed) LV (Completed) EE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002539-24 | Sponsor Protocol Number: MICA | Start Date*: 2012-05-03 | |||||||||||
Sponsor Name:Hospital of the University of Munich | |||||||||||||
Full Title: Effect of Mipomersen on LDL-Cholesterol Levels in Patients with Severe LDL-Hypercholesterolemia and Atherosclerosis Treated by Regular LDL-Apheresis | |||||||||||||
Medical condition: In this trial, the effect of mipomersen is tested on LDL-cholesterol levels in patients with severe LDL-hypercholesterolemia and atherosclerosis which are regularly treated by LDL-apheresis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004935-22 | Sponsor Protocol Number: TA-8995-303 | Start Date*: 2020-10-01 | |||||||||||
Sponsor Name:NewAmsterdam Pharma BV | |||||||||||||
Full Title: A Placebo-Controlled, Double-Blind, Randomized Phase 2 Study to Evaluate the Effect of Obicetrapib in Combination with Ezetimibe in Participants with Mild Dyslipidemia | |||||||||||||
Medical condition: mild dyslipidemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002853-77 | Sponsor Protocol Number: TULIP | Start Date*: 2011-10-20 | |||||||||||
Sponsor Name:Fundació Lluita contra la SIDA | |||||||||||||
Full Title: PROSPECTIVE, RANDOMISED, CROSSOVER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO ASSESS THE LIPID-LOWERING EFFECT OF ADDING TENOFOVIR/EMTRICITABINE CO-FORMULATION VS PLACEBO TO HIV-1-INFECTED SUBJECTS... | |||||||||||||
Medical condition: HIV-1 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006156-36 | Sponsor Protocol Number: EZEHIV06 | Start Date*: 2007-04-27 | |||||||||||
Sponsor Name:Hospital Clinic, Barcelona | |||||||||||||
Full Title: Papel de los niveles plasmáticos de fitosterol en la predicción del efecto hipolipemiante de la ezetimiba en sujetos infectados por VIH que reciben inhibidores de la proteasa. ROLE OF PHYTOSTEROL ... | |||||||||||||
Medical condition: Infección crónica por VIH Hipercolesterolemia Chronic HIV infection hypercholesterolemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002806-59 | Sponsor Protocol Number: LTS11717 | Start Date*: 2012-02-10 | |||||||||||
Sponsor Name:sanofi-aventis Recherche & Développement | |||||||||||||
Full Title: Long-term safety and tolerability of REGN727 / SAR236553 in high cardiovascular risk patients with hypercholesterolemia not adequately controlled with their lipid modifying therapy: a randomized, d... | |||||||||||||
Medical condition: Hypercholesterolaemia. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) FI (Completed) SE (Completed) ES (Completed) PT (Completed) DE (Completed) CZ (Completed) NO (Completed) GB (Completed) NL (Completed) HU (Completed) IT (Completed) DK (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000799-92 | Sponsor Protocol Number: LPS14355 | Start Date*: 2015-12-31 | |||||||||||
Sponsor Name:sanofi-aventis Groupe | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of Alirocumab in insulin treated patients with type 1 or type 2 diabetes and with hyperchole... | |||||||||||||
Medical condition: Hypercholesterolemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) DE (Completed) NL (Completed) AT (Completed) FR (Completed) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001528-39 | Sponsor Protocol Number: 20090158 | Start Date*: 2011-07-13 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: "A Double-blind, Radomized, Placebo-comtrolled, Multicenter Study to Evaluate Tolerability and Efficacy of AMG 145 on LDL-C in Subjects with Heterozygous Familial Hypercholesterolemia" | |||||||||||||
Medical condition: Heterozygous familial hypercholesterolemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) GB (Completed) DE (Completed) SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005140-24 | Sponsor Protocol Number: ISIS 301012-CS19 | Start Date*: 2008-06-05 | |||||||||||
Sponsor Name:Isis Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled STudy to Assess Safety and Efficacy of ISIS 301012 Administration in Statin Intolerant Subjects | |||||||||||||
Medical condition: Patients with hypercholesterolemia who are intolerant to statins | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002849-23 | Sponsor Protocol Number: EFC10841 | Start Date*: 2008-12-04 | |||||||||||
Sponsor Name:Sanofi-Aventis Recherche & Développement | |||||||||||||
Full Title: A multicenter, double-blind, randomized, placebo-controlled study to evaluate the efficacy, safety and tolerability of AVE5530 when added to ongoing stable statin therapy at high doses in patients ... | |||||||||||||
Medical condition: Primary Hypercholesterolemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) FR (Completed) SK (Completed) CZ (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005756-10 | Sponsor Protocol Number: GEM-301 | Start Date*: 2016-05-06 | |||||||||||
Sponsor Name:Gemphire Therapeutics Inc. | |||||||||||||
Full Title: A Phase 2 Randomized, Double-Blind, Dose-Finding Study to Assess the Efficacy, Safety, and Tolerability of Gemcabene in Patients with Hypercholesterolemia on a High-Intensity Stable Statin Therap... | |||||||||||||
Medical condition: Hypercholesterolaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
